Terns Pharmaceuticals (TERN) Debt to Equity (2020)
Terns Pharmaceuticals' Debt to Equity history spans 1 years, with the latest figure at -$0.11 for Q4 2020.
- For Q4 2020, Debt to Equity changed N/A year-over-year to -$0.11; the TTM value through Dec 2020 reached -$0.11, changed N/A, while the annual FY2020 figure was -$0.11, N/A changed from the prior year.
- Debt to Equity reached -$0.11 in Q4 2020 per TERN's latest filing.
- In the past five years, Debt to Equity ranged from a high of -$0.11 in Q4 2020 to a low of -$0.11 in Q4 2020.